首页 > 最新文献

EcoSal Plus最新文献

英文 中文
A history of EcoSal Plus. EcoSal Plus的历史。
Q1 Medicine Pub Date : 2025-12-16 Epub Date: 2025-11-05 DOI: 10.1128/ecosalplus.esp-0011-2025
James B Kaper

EcoSal Plus (ESP) is the authoritative online review journal that publishes an ever-growing body of expert reviews covering virtually all aspects of Escherichia coli, Salmonella, and other members of the order Enterobacterales and their use as model microbes for biological explorations. This review will cover the history of ESP, starting with its origins as multi-volume printed books entitled Escherichia coli and Salmonella: Cellular and Molecular Biology that became "the Bible" for information on the physiology, metabolism, genetics, and other aspects of E. coli and Salmonella. After two printed editions, this resource moved online as EcoSal in an era when electronic publishing was still in its infancy. Progress in establishing EcoSal was slow due to technical issues of online publishing and difficulties in recruiting authors to produce new material. This venture was relaunched in 2013 as EcoSal Plus in a completely new web platform that was much more user (and author) friendly and with an expanded scope to include other members of the order Enterobacterales. EcoSal Plus will be ending as a standalone publication but will merge with Microbiology and Molecular Biology Reviews to continue providing high-quality, authoritative reviews on E. coli, Salmonella, and related organisms.

EcoSal Plus (ESP)是权威的在线评论期刊,发表了一个不断增长的专家评论体,几乎涵盖了大肠杆菌、沙门氏菌和其他肠杆菌目成员的所有方面,以及它们作为生物探索模式微生物的用途。本综述将涵盖ESP的历史,从其多卷印刷书籍《大肠杆菌和沙门氏菌:细胞和分子生物学》的起源开始,这本书成为了大肠杆菌和沙门氏菌生理学、代谢、遗传学和其他方面信息的“圣经”。在出版了两个印刷版之后,在电子出版还处于起步阶段的时代,这本资源以ecsal的名字搬到了网上。由于在线出版的技术问题和招聘作者制作新材料方面的困难,建立ecsal的进展缓慢。该项目于2013年以ecsal Plus的形式在一个全新的网络平台上重新启动,该平台对用户(和作者)更加友好,并且扩展了范围,包括肠杆菌目的其他成员。EcoSal Plus将作为独立出版物结束,但将与微生物学和分子生物学评论合并,继续提供关于大肠杆菌,沙门氏菌和相关生物的高质量,权威的评论。
{"title":"A history of <i>EcoSal Plus</i>.","authors":"James B Kaper","doi":"10.1128/ecosalplus.esp-0011-2025","DOIUrl":"10.1128/ecosalplus.esp-0011-2025","url":null,"abstract":"<p><p><i>EcoSal Plus</i> (ESP) is the authoritative online review journal that publishes an ever-growing body of expert reviews covering virtually all aspects of <i>Escherichia coli</i>, <i>Salmonella</i>, and other members of the order Enterobacterales and their use as model microbes for biological explorations. This review will cover the history of ESP, starting with its origins as multi-volume printed books entitled <i>Escherichia coli and Salmonella: Cellular and Molecular Biology</i> that became \"the Bible\" for information on the physiology, metabolism, genetics, and other aspects of <i>E. coli</i> and <i>Salmonella</i>. After two printed editions, this resource moved online as <i>EcoSal</i> in an era when electronic publishing was still in its infancy. Progress in establishing <i>EcoSal</i> was slow due to technical issues of online publishing and difficulties in recruiting authors to produce new material. This venture was relaunched in 2013 as <i>EcoSal Plus</i> in a completely new web platform that was much more user (and author) friendly and with an expanded scope to include other members of the order Enterobacterales. <i>EcoSal Plus</i> will be ending as a standalone publication but will merge with <i>Microbiology and Molecular Biology Reviews</i> to continue providing high-quality, authoritative reviews on <i>E. coli</i>, <i>Salmonella</i>, and related organisms.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00112025"},"PeriodicalIF":0.0,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145444233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Siderophore cephalosporins. 含铁细胞头孢菌素。
Q1 Medicine Pub Date : 2025-12-16 Epub Date: 2025-04-07 DOI: 10.1128/ecosalplus.esp-0015-2022
Malcolm G P Page

Siderophore cephalosporins are designed to exploit bacterial nutrient uptake systems to gain accelerated uptake across the outer membrane of Gram-negative bacteria. They contain iron (III) binding motifs that allow them to form complexes that will be recognized as potential substrates by iron-siderophore transport systems. Research during the last five decades has culminated in the approval for clinical use of the siderophore cephalosporin cefiderocol, which incorporates accumulated learning from investigations of structural features that enhance resistance toward hydrolysis by β-lactamases, that promote bacterial membrane permeability, and that confer long pharmacokinetic half-life in the human host.

铁载体类头孢菌素被设计为利用细菌营养吸收系统来加速吸收革兰氏阴性菌的外膜。它们含有铁(III)结合基元,使它们能够形成配合物,这些配合物将被铁铁载体运输系统识别为潜在的底物。过去50年的研究最终批准了铁载体头孢菌素cefiderocol的临床应用,该研究结合了从结构特征研究中积累的知识,这些结构特征增强了对β-内酰胺酶水解的抵抗力,促进了细菌膜的通透性,并赋予了人类宿主较长的药代动力学半衰期。
{"title":"Siderophore cephalosporins.","authors":"Malcolm G P Page","doi":"10.1128/ecosalplus.esp-0015-2022","DOIUrl":"10.1128/ecosalplus.esp-0015-2022","url":null,"abstract":"<p><p>Siderophore cephalosporins are designed to exploit bacterial nutrient uptake systems to gain accelerated uptake across the outer membrane of Gram-negative bacteria. They contain iron (III) binding motifs that allow them to form complexes that will be recognized as potential substrates by iron-siderophore transport systems. Research during the last five decades has culminated in the approval for clinical use of the siderophore cephalosporin cefiderocol, which incorporates accumulated learning from investigations of structural features that enhance resistance toward hydrolysis by β-lactamases, that promote bacterial membrane permeability, and that confer long pharmacokinetic half-life in the human host.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00152022"},"PeriodicalIF":0.0,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143794939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The bacteriophage T4 homologous recombination system: mechanism, applications, conservation, and environmental significance. 噬菌体T4同源重组体系:机制、应用、保护及环境意义
Q1 Medicine Pub Date : 2025-12-16 Epub Date: 2025-09-16 DOI: 10.1128/ecosalplus.esp-0003-2025
Scott W Morrical

The homologous recombination (HR) system of bacteriophage T4 plays critical, direct roles in the replication and repair of the phage genome. This review covers the classic, UvsX-dependent HR pathway in T4, focusing on recent findings on the mechanisms of central HR proteins UvsX, UvsY, and Gp32, plus the key helicase and nuclease enzymes that affect HR and promote its coupling to T4 recombination-dependent replication and repair processes. The T4 HR pathways are paradigmatic, since they are highly conserved in all orders of viral and cellular life. Therefore, the study of T4 recombination is highly relevant to biomedicine and to environmental microbiology. At the same time, the tractability of the T4 recombination system for biochemical studies has led to the development of novel, isothermal DNA amplification technologies based on the activities of UvsX, UvsY, and Gp32, which are discussed herein. Globally, the recent revolution in metagenomics has demonstrated that T4-like phages, most encoding the genes and proteins of the T4 HR system, are abundant and widespread in the environment, where they play important roles in the dynamics of diverse microbiomes, from the earth's oceans to the animal gut. Accordingly, we discuss the conservation of T4 HR genes in representatives of T4-like jumbo phages and cyanophages. As a paradigm for HR in diverse organisms, as a source of novel technologies, and as a window on the importance of bacteriophages in the environment, the T4 HR system continues to provide new insights and reagents for a better understanding of life on earth.

噬菌体T4的同源重组(HR)系统在噬菌体基因组的复制和修复中起着至关重要的直接作用。本文综述了T4中经典的、依赖于UvsX的HR通路,重点介绍了核心HR蛋白UvsX、UvsY和Gp32的机制,以及影响HR并促进其耦合到T4重组依赖的复制和修复过程的关键解旋酶和核酸酶的最新发现。T4 - HR通路是典型的,因为它们在所有的病毒和细胞生命中都是高度保守的。因此,T4重组的研究与生物医学和环境微生物学具有高度的相关性。同时,由于T4重组系统在生化研究中的可追溯性,基于UvsX、UvsY和Gp32活性的新型等温DNA扩增技术得到了发展,本文对此进行了讨论。在全球范围内,最近宏基因组学的革命表明,T4样噬菌体(大多数编码T4 HR系统的基因和蛋白质)在环境中数量丰富且广泛存在,它们在从地球海洋到动物肠道的各种微生物组的动态中发挥重要作用。因此,我们讨论了T4 HR基因在T4样巨型噬菌体和蓝噬体中的保守性。作为多种生物中HR的范例,作为新技术的来源,以及作为噬菌体在环境中的重要性的窗口,T4 HR系统继续为更好地理解地球上的生命提供新的见解和试剂。
{"title":"The bacteriophage T4 homologous recombination system: mechanism, applications, conservation, and environmental significance.","authors":"Scott W Morrical","doi":"10.1128/ecosalplus.esp-0003-2025","DOIUrl":"10.1128/ecosalplus.esp-0003-2025","url":null,"abstract":"<p><p>The homologous recombination (HR) system of bacteriophage T4 plays critical, direct roles in the replication and repair of the phage genome. This review covers the classic, UvsX-dependent HR pathway in T4, focusing on recent findings on the mechanisms of central HR proteins UvsX, UvsY, and Gp32, plus the key helicase and nuclease enzymes that affect HR and promote its coupling to T4 recombination-dependent replication and repair processes. The T4 HR pathways are paradigmatic, since they are highly conserved in all orders of viral and cellular life. Therefore, the study of T4 recombination is highly relevant to biomedicine and to environmental microbiology. At the same time, the tractability of the T4 recombination system for biochemical studies has led to the development of novel, isothermal DNA amplification technologies based on the activities of UvsX, UvsY, and Gp32, which are discussed herein. Globally, the recent revolution in metagenomics has demonstrated that T4-like phages, most encoding the genes and proteins of the T4 HR system, are abundant and widespread in the environment, where they play important roles in the dynamics of diverse microbiomes, from the earth's oceans to the animal gut. Accordingly, we discuss the conservation of T4 HR genes in representatives of T4-like jumbo phages and cyanophages. As a paradigm for HR in diverse organisms, as a source of novel technologies, and as a window on the importance of bacteriophages in the environment, the T4 HR system continues to provide new insights and reagents for a better understanding of life on earth.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00032025"},"PeriodicalIF":0.0,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707138/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145069202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatio-temporal organization of the E. coli chromosome from base to cellular length scales. 从碱基到细胞长度尺度的大肠杆菌染色体时空组织。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-06-12 DOI: 10.1128/ecosalplus.esp-0001-2022
Sonya K Royzenblat, Lydia Freddolino

Escherichia coli has been a vital model organism for studying chromosomal structure, thanks, in part, to its small and circular genome (4.6 million base pairs) and well-characterized biochemical pathways. Over the last several decades, we have made considerable progress in understanding the intricacies of the structure and subsequent function of the E. coli nucleoid. At the smallest scale, DNA, with no physical constraints, takes on a shape reminiscent of a randomly twisted cable, forming mostly random coils but partly affected by its stiffness. This ball-of-spaghetti-like shape forms a structure several times too large to fit into the cell. Once the physiological constraints of the cell are added, the DNA takes on overtwisted (negatively supercoiled) structures, which are shaped by an intricate interplay of many proteins carrying out essential biological processes. At shorter length scales (up to about 1 kb), nucleoid-associated proteins organize and condense the chromosome by inducing loops, bends, and forming bridges. Zooming out further and including cellular processes, topological domains are formed, which are flanked by supercoiling barriers. At the megabase-scale both large, highly self-interacting regions (macrodomains) and strong contacts between distant but co-regulated genes have been observed. At the largest scale, the nucleoid forms a helical ellipsoid. In this review, we will explore the history and recent advances that pave the way for a better understanding of E. coli chromosome organization and structure, discussing the cellular processes that drive changes in DNA shape, and what contributes to compaction and formation of dynamic structures, and in turn how bacterial chromatin affects key processes such as transcription and replication.

大肠杆菌一直是研究染色体结构的重要模式生物,这部分归功于它的小而圆的基因组(460 万碱基对)和特征良好的生化途径。过去几十年来,我们在了解大肠杆菌核团结构及其功能方面取得了长足的进步。在最小尺度上,DNA 在没有物理约束的情况下,其形状让人联想到随机扭曲的电缆,形成的线圈大部分是随机的,但部分受到其硬度的影响。这种面条球状的形状形成了一个大数倍的结构,无法装入细胞。一旦加上细胞的生理限制,DNA 就会形成过度扭曲(负超卷)的结构,这种结构是由许多执行重要生物过程的蛋白质错综复杂地相互作用形成的。在较短的长度范围内(最多约 1 kb),核团相关蛋白通过诱导环、弯曲和形成桥来组织和凝结染色体。进一步放大,包括细胞过程在内,拓扑结构域形成,其两侧是超卷曲屏障。在巨碱基尺度上,既观察到了大型、高度自我相互作用的区域(宏域),也观察到了相距遥远但共同调控的基因之间的强烈接触。在最大尺度上,核团形成一个螺旋椭圆体。在这篇综述中,我们将探讨为更好地了解大肠杆菌染色体组织和结构铺平道路的历史和最新进展,讨论驱动 DNA 形状变化的细胞过程、促成压实和动态结构形成的因素,以及细菌染色质如何反过来影响转录和复制等关键过程。
{"title":"Spatio-temporal organization of the <i>E. coli</i> chromosome from base to cellular length scales.","authors":"Sonya K Royzenblat, Lydia Freddolino","doi":"10.1128/ecosalplus.esp-0001-2022","DOIUrl":"10.1128/ecosalplus.esp-0001-2022","url":null,"abstract":"<p><p><i>Escherichia coli</i> has been a vital model organism for studying chromosomal structure, thanks, in part, to its small and circular genome (4.6 million base pairs) and well-characterized biochemical pathways. Over the last several decades, we have made considerable progress in understanding the intricacies of the structure and subsequent function of the <i>E. coli</i> nucleoid. At the smallest scale, DNA, with no physical constraints, takes on a shape reminiscent of a randomly twisted cable, forming mostly random coils but partly affected by its stiffness. This ball-of-spaghetti-like shape forms a structure several times too large to fit into the cell. Once the physiological constraints of the cell are added, the DNA takes on overtwisted (negatively supercoiled) structures, which are shaped by an intricate interplay of many proteins carrying out essential biological processes. At shorter length scales (up to about 1 kb), nucleoid-associated proteins organize and condense the chromosome by inducing loops, bends, and forming bridges. Zooming out further and including cellular processes, topological domains are formed, which are flanked by supercoiling barriers. At the megabase-scale both large, highly self-interacting regions (macrodomains) and strong contacts between distant but co-regulated genes have been observed. At the largest scale, the nucleoid forms a helical ellipsoid. In this review, we will explore the history and recent advances that pave the way for a better understanding of <i>E. coli</i> chromosome organization and structure, discussing the cellular processes that drive changes in DNA shape, and what contributes to compaction and formation of dynamic structures, and in turn how bacterial chromatin affects key processes such as transcription and replication.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00012022"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic engineering of Salmonella spp. for novel vaccine strategies and therapeutics. 用于新型疫苗战略和治疗的沙门氏菌属基因工程。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-07-18 DOI: 10.1128/ecosalplus.esp-0004-2023
Garima Bansal, Mostafa Ghanem, Khandra T Sears, James E Galen, Sharon M Tennant

Salmonella enterica is a diverse species that infects both humans and animals. S. enterica subspecies enterica consists of more than 1,500 serovars. Unlike typhoidal Salmonella serovars which are human host-restricted, non-typhoidal Salmonella (NTS) serovars are associated with foodborne illnesses worldwide and are transmitted via the food chain. Additionally, NTS serovars can cause disease in livestock animals causing significant economic losses. Salmonella is a well-studied model organism that is easy to manipulate and evaluate in animal models of infection. Advances in genetic engineering approaches in recent years have led to the development of Salmonella vaccines for both humans and animals. In this review, we focus on current progress of recombinant live-attenuated Salmonella vaccines, their use as a source of antigens for parenteral vaccines, their use as live-vector vaccines to deliver foreign antigens, and their use as therapeutic cancer vaccines in humans. We also describe development of live-attenuated Salmonella vaccines and live-vector vaccines for use in animals.

肠炎沙门氏菌种类繁多,可感染人类和动物。肠炎沙门氏菌亚种由 1 500 多个血清型组成。伤寒型沙门氏菌血清对人类宿主有限制,而非伤寒型沙门氏菌(NTS)血清则与世界各地的食源性疾病有关,并通过食物链传播。此外,非伤寒沙门氏菌(NTS)血清型还可导致家畜患病,造成重大经济损失。沙门氏菌是一种经过充分研究的模式生物,易于在动物感染模型中进行操作和评估。近年来,基因工程方法的进步促进了人类和动物沙门氏菌疫苗的开发。在这篇综述中,我们将重点介绍重组减毒沙门氏菌活疫苗的最新进展、其作为肠外疫苗抗原来源的用途、其作为活载体疫苗传递外来抗原的用途,以及其作为人类治疗性癌症疫苗的用途。我们还介绍了用于动物的沙门氏菌减毒活疫苗和活载体疫苗的开发情况。
{"title":"Genetic engineering of <i>Salmonella</i> spp. for novel vaccine strategies and therapeutics.","authors":"Garima Bansal, Mostafa Ghanem, Khandra T Sears, James E Galen, Sharon M Tennant","doi":"10.1128/ecosalplus.esp-0004-2023","DOIUrl":"10.1128/ecosalplus.esp-0004-2023","url":null,"abstract":"<p><p><i>Salmonella enterica</i> is a diverse species that infects both humans and animals. <i>S. enterica</i> subspecies <i>enterica</i> consists of more than 1,500 serovars. Unlike typhoidal <i>Salmonella</i> serovars which are human host-restricted, non-typhoidal <i>Salmonella</i> (NTS) serovars are associated with foodborne illnesses worldwide and are transmitted via the food chain. Additionally, NTS serovars can cause disease in livestock animals causing significant economic losses. <i>Salmonella</i> is a well-studied model organism that is easy to manipulate and evaluate in animal models of infection. Advances in genetic engineering approaches in recent years have led to the development of <i>Salmonella</i> vaccines for both humans and animals. In this review, we focus on current progress of recombinant live-attenuated <i>Salmonella</i> vaccines, their use as a source of antigens for parenteral vaccines, their use as live-vector vaccines to deliver foreign antigens, and their use as therapeutic cancer vaccines in humans. We also describe development of live-attenuated <i>Salmonella</i> vaccines and live-vector vaccines for use in animals.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00042023"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type IV pili of Enterobacteriaceae species. 肠杆菌科物种的 IV 型纤毛虫。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-01-31 DOI: 10.1128/ecosalplus.esp-0003-2023
Janay I Little, Pradip K Singh, Jinlei Zhao, Shakeera Dunn, Hanover Matz, Michael S Donnenberg

Type IV pili (T4Ps) are surface filaments widely distributed among bacteria and archaea. T4Ps are involved in many cellular functions and contribute to virulence in some species of bacteria. Due to the diversity of T4Ps, different properties have been observed for homologous proteins that make up T4Ps in various organisms. In this review, we highlight the essential components of T4Ps, their functions, and similarities to related systems. We emphasize the unique T4Ps of enteric pathogens within the Enterobacteriaceae family, which includes pathogenic strains of Escherichia coli and Salmonella. These include the bundle-forming pilus (BFP) of enteropathogenic E. coli (EPEC), longus (Lng) and colonization factor III (CFA/III) of enterotoxigenic E. coli (ETEC), T4P of Salmonella enterica serovar Typhi, Colonization Factor Citrobacter (CFC) of Citrobacter rodentium, T4P of Yersinia pseudotuberculosis, a ubiquitous T4P that was characterized in enterohemorrhagic E. coli (EHEC), and the R64 plasmid thin pilus. Finally, we highlight areas for further study.

第四型纤毛(T4Ps)是广泛分布于细菌和古细菌中的表面丝状物。T4Ps 参与了许多细胞功能,并对某些种类细菌的毒力有影响。由于 T4Ps 的多样性,在不同生物体中组成 T4Ps 的同源蛋白也具有不同的特性。在本综述中,我们将重点介绍 T4Ps 的基本成分、功能以及与相关系统的相似性。我们强调肠杆菌科肠道病原体(包括大肠杆菌和沙门氏菌的致病菌株)特有的 T4Ps。这些T4Ps包括肠致病性大肠杆菌(EPEC)的成束柔毛(BFP)、肠致病性大肠杆菌(ETEC)的长柔毛(Lng)和定植因子III(CFA/III)、肠致病性大肠杆菌(EPEC)和沙门氏菌(Salmonella)的T4Ps。大肠杆菌(ETEC)的 T4P、伤寒沙门氏菌(Salmonella enterica serovar Typhi)的 T4P、枸橼酸杆菌(Citrobacter rodentium)的定植因子(CFC)、耶尔森氏菌(Yersinia pseudotuberculosis)的 T4P、肠出血性大肠杆菌(EHEC)中的一种无处不在的 T4P 以及 R64 质粒细螺旋体。最后,我们强调了有待进一步研究的领域。
{"title":"Type IV pili of <i>Enterobacteriaceae</i> species.","authors":"Janay I Little, Pradip K Singh, Jinlei Zhao, Shakeera Dunn, Hanover Matz, Michael S Donnenberg","doi":"10.1128/ecosalplus.esp-0003-2023","DOIUrl":"10.1128/ecosalplus.esp-0003-2023","url":null,"abstract":"<p><p>Type IV pili (T4Ps) are surface filaments widely distributed among bacteria and archaea. T4Ps are involved in many cellular functions and contribute to virulence in some species of bacteria. Due to the diversity of T4Ps, different properties have been observed for homologous proteins that make up T4Ps in various organisms. In this review, we highlight the essential components of T4Ps, their functions, and similarities to related systems. We emphasize the unique T4Ps of enteric pathogens within the <i>Enterobacteriaceae</i> family, which includes pathogenic strains of <i>Escherichia coli</i> and <i>Salmonella</i>. These include the bundle-forming pilus (BFP) of enteropathogenic <i>E. coli</i> (EPEC), longus (Lng) and colonization factor III (CFA/III) of enterotoxigenic <i>E. coli</i> (ETEC), T4P of <i>Salmonella enterica</i> serovar Typhi, Colonization Factor Citrobacter (CFC) of <i>Citrobacter rodentium</i>, T4P of <i>Yersinia pseudotuberculosis</i>, a ubiquitous T4P that was characterized in enterohemorrhagic <i>E. coli</i> (EHEC), and the R64 plasmid thin pilus. Finally, we highlight areas for further study.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00032023"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139641811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type I toxin-antitoxin systems in bacteria: from regulation to biological functions. 细菌中的 I 型毒素-抗毒素系统:从调节到生物功能。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-05-20 DOI: 10.1128/ecosalplus.esp-0025-2022
Selene F H Shore, Florian H Leinberger, Elizabeth M Fozo, Bork A Berghoff

Toxin-antitoxin systems are ubiquitous in the prokaryotic world and widely distributed among chromosomes and mobile genetic elements. Several different toxin-antitoxin system types exist, but what they all have in common is that toxin activity is prevented by the cognate antitoxin. In type I toxin-antitoxin systems, toxin production is controlled by an RNA antitoxin and by structural features inherent to the toxin messenger RNA. Most type I toxins are small membrane proteins that display a variety of cellular effects. While originally discovered as modules that stabilize plasmids, chromosomal type I toxin-antitoxin systems may also stabilize prophages, or serve important functions upon certain stress conditions and contribute to population-wide survival strategies. Here, we will describe the intricate RNA-based regulation of type I toxin-antitoxin systems and discuss their potential biological functions.

毒素-抗毒素系统在原核生物中无处不在,广泛分布于染色体和移动遗传因子中。毒素-抗毒素系统有几种不同的类型,但它们的共同点都是毒素活性被同源的抗毒素所阻止。在 I 型毒素-抗毒素系统中,毒素的产生受 RNA 抗毒素和毒素信使 RNA 固有结构特征的控制。大多数 I 型毒素都是小型膜蛋白,能产生多种细胞效应。虽然最初是作为稳定质粒的模块被发现的,但染色体 I 型毒素-抗毒素系统也可能稳定原生质粒,或在某些应激条件下发挥重要功能,并有助于整个种群的生存策略。在这里,我们将描述 I 型毒素-抗毒素系统基于 RNA 的复杂调控,并讨论其潜在的生物学功能。
{"title":"Type I toxin-antitoxin systems in bacteria: from regulation to biological functions.","authors":"Selene F H Shore, Florian H Leinberger, Elizabeth M Fozo, Bork A Berghoff","doi":"10.1128/ecosalplus.esp-0025-2022","DOIUrl":"10.1128/ecosalplus.esp-0025-2022","url":null,"abstract":"<p><p>Toxin-antitoxin systems are ubiquitous in the prokaryotic world and widely distributed among chromosomes and mobile genetic elements. Several different toxin-antitoxin system types exist, but what they all have in common is that toxin activity is prevented by the cognate antitoxin. In type I toxin-antitoxin systems, toxin production is controlled by an RNA antitoxin and by structural features inherent to the toxin messenger RNA. Most type I toxins are small membrane proteins that display a variety of cellular effects. While originally discovered as modules that stabilize plasmids, chromosomal type I toxin-antitoxin systems may also stabilize prophages, or serve important functions upon certain stress conditions and contribute to population-wide survival strategies. Here, we will describe the intricate RNA-based regulation of type I toxin-antitoxin systems and discuss their potential biological functions.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00252022"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636113/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141065100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcription activation in Escherichia coli and Salmonella. 大肠杆菌和沙门氏菌的转录激活。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-02-12 DOI: 10.1128/ecosalplus.esp-0039-2020
Stephen J W Busby, Douglas F Browning

Promoter-specific activation of transcript initiation provides an important regulatory device in Escherichia coli and Salmonella. Here, we describe the different mechanisms that operate, focusing on how they have evolved to manage the "housekeeping" bacterial transcription machinery. Some mechanisms involve assisting the bacterial DNA-dependent RNA polymerase or replacing or remodeling one of its subunits. Others are directed to chromosomal DNA, improving promoter function, or relieving repression. We discuss how different activators work together at promoters and how the present complex network of transcription factors evolved.

在大肠杆菌和沙门氏菌中,启动子特异性激活转录本启动是一种重要的调控手段。在这里,我们描述了不同的运作机制,重点是它们是如何进化来管理 "看家 "细菌转录机制的。一些机制涉及辅助细菌的 DNA 依赖性 RNA 聚合酶,或替换或重塑其一个亚基。其他机制则针对染色体 DNA、改善启动子功能或缓解抑制。我们将讨论不同的激活因子如何在启动子上协同工作,以及目前复杂的转录因子网络是如何演变而来的。
{"title":"Transcription activation in <i>Escherichia coli</i> and <i>Salmonella</i>.","authors":"Stephen J W Busby, Douglas F Browning","doi":"10.1128/ecosalplus.esp-0039-2020","DOIUrl":"10.1128/ecosalplus.esp-0039-2020","url":null,"abstract":"<p><p>Promoter-specific activation of transcript initiation provides an important regulatory device in <i>Escherichia coli</i> and <i>Salmonella</i>. Here, we describe the different mechanisms that operate, focusing on how they have evolved to manage the \"housekeeping\" bacterial transcription machinery. Some mechanisms involve assisting the bacterial DNA-dependent RNA polymerase or replacing or remodeling one of its subunits. Others are directed to chromosomal DNA, improving promoter function, or relieving repression. We discuss how different activators work together at promoters and how the present complex network of transcription factors evolved.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00392020"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636354/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139722108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrition of Escherichia coli within the intestinal microbiome 肠道微生物群中大肠杆菌的营养状况
Q1 Medicine Pub Date : 2024-01-11 DOI: 10.1128/ecosalplus.esp-0006-2023
Sudhir Doranga, K. A. Krogfelt, Paul S. Cohen, Tyrrell Conway
ABSTRACT In this chapter, we update our 2004 review of “The Life of Commensal Escherichia coli in the Mammalian Intestine” (https://doi.org/10.1128/ecosalplus.8.3.1.2), with a change of title that reflects the current focus on “Nutrition of E. coli within the Intestinal Microbiome.” The earlier part of the previous two decades saw incremental improvements in understanding the carbon and energy sources that E. coli and Salmonella use to support intestinal colonization. Along with these investigations of electron donors came a better understanding of the electron acceptors that support the respiration of these facultative anaerobes in the gastrointestinal tract. Hundreds of recent papers add to what was known about the nutrition of commensal and pathogenic enteric bacteria. The fact that each biotype or pathotype grows on a different subset of the available nutrients suggested a mechanism for succession of commensal colonizers and invasion by enteric pathogens. Competition for nutrients in the intestine has also come to be recognized as one basis for colonization resistance, in which colonized strain(s) prevent colonization by a challenger. In the past decade, detailed investigations of fiber- and mucin-degrading anaerobes added greatly to our understanding of how complex polysaccharides support the hundreds of intestinal microbiome species. It is now clear that facultative anaerobes, which usually cannot degrade complex polysaccharides, live in symbiosis with the anaerobic degraders. This concept led to the “restaurant hypothesis,” which emphasizes that facultative bacteria, such as E. coli, colonize the intestine as members of mixed biofilms and obtain the sugars they need for growth locally through cross-feeding from polysaccharide-degrading anaerobes. Each restaurant represents an intestinal niche. Competition for those niches determines whether or not invaders are able to overcome colonization resistance and become established. Topics centered on the nutritional basis of intestinal colonization and gastrointestinal health are explored here in detail.
摘要 在本章中,我们更新了 2004 年对 "哺乳动物肠道中共生大肠埃希氏菌的生活"(https://doi.org/10.1128/ecosalplus.8.3.1.2)的评论,标题的改变反映了当前对 "肠道微生物组中大肠埃希氏菌的营养 "的关注。在过去二十年的早期,人们对大肠杆菌和沙门氏菌用于支持肠道定植的碳源和能量源的了解逐步加深。随着对电子供体的研究,人们对支持这些变性厌氧菌在胃肠道内呼吸的电子受体也有了更好的了解。最近的数百篇论文增加了人们对肠道共生菌和致病菌营养的了解。事实上,每种生物型或病理型都生长在不同的可用营养物质子集上,这表明共生菌定植者的继承和肠道病原体的入侵是一种机制。肠道中的营养竞争也被认为是定植抵抗的基础之一,在这种情况下,定植菌株会阻止挑战者的定植。在过去十年中,对纤维和粘蛋白降解厌氧菌的详细研究大大加深了我们对复杂多糖如何支持数百种肠道微生物群的理解。现在很清楚,通常不能降解复杂多糖的兼性厌氧菌与厌氧降解菌共生。这一概念导致了 "餐厅假说",它强调大肠杆菌等兼性细菌作为混合生物膜的成员在肠道中定植,并通过与降解多糖的厌氧菌交叉觅食获得生长所需的糖分。每家餐厅都代表着一个肠道生态位。对这些生态位的争夺决定了入侵者是否能够克服定植阻力并站稳脚跟。这里将详细探讨以肠道定植和肠道健康的营养基础为中心的主题。
{"title":"Nutrition of Escherichia coli within the intestinal microbiome","authors":"Sudhir Doranga, K. A. Krogfelt, Paul S. Cohen, Tyrrell Conway","doi":"10.1128/ecosalplus.esp-0006-2023","DOIUrl":"https://doi.org/10.1128/ecosalplus.esp-0006-2023","url":null,"abstract":"ABSTRACT In this chapter, we update our 2004 review of “The Life of Commensal Escherichia coli in the Mammalian Intestine” (https://doi.org/10.1128/ecosalplus.8.3.1.2), with a change of title that reflects the current focus on “Nutrition of E. coli within the Intestinal Microbiome.” The earlier part of the previous two decades saw incremental improvements in understanding the carbon and energy sources that E. coli and Salmonella use to support intestinal colonization. Along with these investigations of electron donors came a better understanding of the electron acceptors that support the respiration of these facultative anaerobes in the gastrointestinal tract. Hundreds of recent papers add to what was known about the nutrition of commensal and pathogenic enteric bacteria. The fact that each biotype or pathotype grows on a different subset of the available nutrients suggested a mechanism for succession of commensal colonizers and invasion by enteric pathogens. Competition for nutrients in the intestine has also come to be recognized as one basis for colonization resistance, in which colonized strain(s) prevent colonization by a challenger. In the past decade, detailed investigations of fiber- and mucin-degrading anaerobes added greatly to our understanding of how complex polysaccharides support the hundreds of intestinal microbiome species. It is now clear that facultative anaerobes, which usually cannot degrade complex polysaccharides, live in symbiosis with the anaerobic degraders. This concept led to the “restaurant hypothesis,” which emphasizes that facultative bacteria, such as E. coli, colonize the intestine as members of mixed biofilms and obtain the sugars they need for growth locally through cross-feeding from polysaccharide-degrading anaerobes. Each restaurant represents an intestinal niche. Competition for those niches determines whether or not invaders are able to overcome colonization resistance and become established. Topics centered on the nutritional basis of intestinal colonization and gastrointestinal health are explored here in detail.","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":"3 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The rise, fall, and resurgence of phage therapy for urinary tract infection 噬菌体疗法治疗尿路感染的兴衰与复苏
Q1 Medicine Pub Date : 2024-01-11 DOI: 10.1128/ecosalplus.esp-0029-2023
J. Zulk, K. Patras, A. Maresso
ABSTRACT In the face of rising antimicrobial resistance, bacteriophage therapy, also known as phage therapy, is seeing a resurgence as a potential treatment for bacterial infections including urinary tract infection (UTI). Primarily caused by uropathogenic Escherichia coli, the 400 million UTI cases annually are major global healthcare burdens and a primary cause of antibiotic prescriptions in the outpatient setting. Phage therapy has several potential advantages over antibiotics including the ability to disrupt bacterial biofilms and synergize with antimicrobial treatments with minimal side effects or impacts on the microbiota. Phage therapy for UTI treatment has shown generally favorable results in recent animal models and human case reports. Ongoing clinical trials seek to understand the efficacy of phage therapy in individuals with asymptomatic bacteriuria and uncomplicated cystitis. A possible challenge for phage therapy is the development of phage resistance in bacteria during treatment. While resistance frequently develops in vitro and in vivo, resistance can come with negative consequences for the bacteria, leaving them susceptible to antibiotics and other environmental conditions and reducing their overall virulence. “Steering” bacteria toward phage resistance outcomes that leave them less fit or virulent is especially useful in the context of UTI where poorly adherent or slow-growing bacteria are likely to be flushed from the system. In this article, we describe the history of phage therapy in treating UTI and its current resurgence, the state of its clinical use, and an outlook on how well-designed phage therapy could be used to “steer” bacteria toward less virulent and antimicrobial-susceptible states.
摘要 面对抗菌药耐药性的不断上升,噬菌体疗法(又称噬菌体疗法)作为一种潜在的治疗细菌感染(包括尿路感染)的方法正在重新兴起。尿路感染主要由尿路致病性大肠杆菌引起,每年有 4 亿尿路感染病例,是全球医疗保健的主要负担,也是门诊抗生素处方的主要原因。与抗生素相比,噬菌体疗法有几个潜在的优势,包括能破坏细菌生物膜,与抗菌治疗协同作用,且副作用或对微生物群的影响最小。在最近的动物模型和人类病例报告中,噬菌体疗法治疗UTI的效果普遍良好。正在进行的临床试验旨在了解噬菌体疗法对无症状菌尿和无并发症膀胱炎患者的疗效。噬菌体疗法可能面临的一个挑战是在治疗过程中细菌产生噬菌体抗药性。虽然抗药性经常在体外和体内产生,但抗药性会给细菌带来负面影响,使其容易受到抗生素和其他环境条件的影响,并降低其整体毒力。将细菌 "引导 "至噬菌体产生抗药性的结果,降低它们的适应性或毒力,这对UTI 尤为有用,因为在UTI 中,粘附性差或生长缓慢的细菌很可能会被冲出系统。在本文中,我们将介绍噬菌体疗法治疗UTI的历史及其目前的复苏情况、临床应用现状,并展望如何利用精心设计的噬菌体疗法将细菌 "引导 "至毒力较低和对抗菌素敏感的状态。
{"title":"The rise, fall, and resurgence of phage therapy for urinary tract infection","authors":"J. Zulk, K. Patras, A. Maresso","doi":"10.1128/ecosalplus.esp-0029-2023","DOIUrl":"https://doi.org/10.1128/ecosalplus.esp-0029-2023","url":null,"abstract":"ABSTRACT In the face of rising antimicrobial resistance, bacteriophage therapy, also known as phage therapy, is seeing a resurgence as a potential treatment for bacterial infections including urinary tract infection (UTI). Primarily caused by uropathogenic Escherichia coli, the 400 million UTI cases annually are major global healthcare burdens and a primary cause of antibiotic prescriptions in the outpatient setting. Phage therapy has several potential advantages over antibiotics including the ability to disrupt bacterial biofilms and synergize with antimicrobial treatments with minimal side effects or impacts on the microbiota. Phage therapy for UTI treatment has shown generally favorable results in recent animal models and human case reports. Ongoing clinical trials seek to understand the efficacy of phage therapy in individuals with asymptomatic bacteriuria and uncomplicated cystitis. A possible challenge for phage therapy is the development of phage resistance in bacteria during treatment. While resistance frequently develops in vitro and in vivo, resistance can come with negative consequences for the bacteria, leaving them susceptible to antibiotics and other environmental conditions and reducing their overall virulence. “Steering” bacteria toward phage resistance outcomes that leave them less fit or virulent is especially useful in the context of UTI where poorly adherent or slow-growing bacteria are likely to be flushed from the system. In this article, we describe the history of phage therapy in treating UTI and its current resurgence, the state of its clinical use, and an outlook on how well-designed phage therapy could be used to “steer” bacteria toward less virulent and antimicrobial-susceptible states.","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":"11 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
EcoSal Plus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1